Immunotherapy in the Management of Lung Cancer

Immunotherapy in the Management of Lung Cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Opis bibliograficzny
1. autor:	Tasnim, Humayra
Kolejni autorzy:	khan, Tanisha Tabassum Sayka
Format:	Praca dyplomowa
Język:	en_US
Wydane:	Brac University 2022
Hasła przedmiotowe:	Lung cancer Immunotherapy Cytokines Checkpoint inhibitors Adoptive cell therapy Vaccines Cancer > Treatment Cancer > Immunotherapy
Dostęp online:	http://hdl.handle.net/10361/17515

Podobne zapisy

Current practice and approaches of immunotherapy in Cancer treatment
od: Khondokar, Faiza
Wydane: (2022)

A review on targeted therapies for lung cancer
od: Ashraf, Anushey
Wydane: (2023)

Immunotherapy in the treatment of renal cancer
od: Shimu, Sumaya
Wydane: (2022)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
od: Ratu, Tabassum
Wydane: (2024)

Immunotherapeutic approaches to treat cancer: Prospects and challenges
od: Fred, Namanda Rogers
Wydane: (2021)

A review paper on Nanotechnology based strategies in the treatment of cancer
od: Rahman, Samia
Wydane: (2022)

CAR-T cell Therapy in B-cell Lymphoma
od: Faruk, Asef
Wydane: (2020)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
od: Flora, Sanzida Alam
Wydane: (2024)

Dendritic cell vaccine for the treatment of cancer
od: Haque, Tanzila
Wydane: (2023)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
od: Abir, Shifaty Nur
Wydane: (2024)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
od: Bristy, Israt Zerin
Wydane: (2021)

Role of toll-like receptors in cancer immunotherapy– a review
od: Khan, Rezia Nowrin
Wydane: (2021)

Stem cell in cancer disease cure vs cause
od: Chowdhury, Marisha Mansur
Wydane: (2023)

RIPK pathway, as a potential target, for cancer treatment - a review
od: Jahan, Nusrat
Wydane: (2024)

Molecules associated with the development of lung cancer
od: Rahman, Adree, i wsp.
Wydane: (2023)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
od: Rahman, Sanjida
Wydane: (2024)

Potential of liposomes for the treatment of lung cancer- a review
od: Mim, Shanzida
Wydane: (2023)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
od: Rahman, Tasnim
Wydane: (2024)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
od: Tania, Umme
Wydane: (2023)

A review on recent advances in drugs for lung cancer treatment
od: Noor, Fouzia
Wydane: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
od: Jeba, Joynob
Wydane: (2017)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
od: Razna, Amrin Islam
Wydane: (2019)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
od: Meem, Manila
Wydane: (2023)

A review on potential of PARP inhibitors in the treatment of prostate cancer
od: Islam, Saidul
Wydane: (2022)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
od: Pial, Sazia Afrin
Wydane: (2018)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
od: Paul, Pulock
Wydane: (2024)

Stem cells as therapeutic carrier in cancer treatment
od: Anika, Mysha Yeasmin
Wydane: (2022)

Recent advances in Cancer treatment targeting autophagy and future aspects
od: Emon, Kamrul Hasan
Wydane: (2022)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
od: Shabnam, Musharrat
Wydane: (2018)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
od: Zangmo, Thinley
Wydane: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
od: Hoque, Ismoth Ara
Wydane: (2024)

A comprehensive review on drug repurposing in cancer treatment
od: Sarkar, Onusree
Wydane: (2024)

Lung cancer detection and classification using machine learning
od: Arefin, Mahbubul, i wsp.
Wydane: (2023)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
od: Nandy, Aditi
Wydane: (2022)

Targeted therapeutic options in the treatment of Breast Cancer
od: Alam, Kazi Tasnuva
Wydane: (2022)

Molecular biology of cancer : mechanisms, targets, and therapeutics /
od: Pecorino, Lauren
Wydane: (2012)

Statistics and informatics in molecular cancer research

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
od: Khan, Muidul Hasan
Wydane: (2024)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
od: Kamal, Tasnova
Wydane: (2019)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
od: Hasan, Amit
Wydane: (2024)